Early research (Phase 1)Study completedNCT02103894
What this trial is testing
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Who this might be right for
Alzheimer's Disease (AD)Parkinson's Disease (PD)Chronic Traumatic Encephalopathy (CTE)+4 more
Molecular NeuroImaging 16